This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
De Novo
De Novo
The US Food and Drug Administration (FDA) automatically classifies Class I or II medical devices without a predicate as class III.
De novo process allows these low risk devices to be re-classified via a request for a risk-based (re)classification from the FDA.
If rejected, the device will remain class III (and consequently request a PMA application). A similar level of product information as a 510 (k) clearance process is expected by the FDA.
De Novo procedure is currently not widely used procedure however utilized increasingly.